147 related articles for article (PubMed ID: 8951966)
21. Effects of the non-NMDA antagonists NBQX and the 2,3-benzodiazepine GYKI 52466 on different seizure types in mice: comparison with diazepam and interactions with flumazenil.
Löscher W; Hönack D
Br J Pharmacol; 1994 Dec; 113(4):1349-57. PubMed ID: 7889291
[TBL] [Abstract][Full Text] [Related]
22. Anticonvulsant activity of a mGlu(4alpha) receptor selective agonist, (1S,3R,4S)-1-aminocyclopentane-1,2,4-tricarboxylic acid.
Chapman AG; Talebi A; Yip PK; Meldrum BS
Eur J Pharmacol; 2001 Jul; 424(2):107-13. PubMed ID: 11476756
[TBL] [Abstract][Full Text] [Related]
23. Selective antagonism of the anticonvulsant effects of felbamate by glycine.
Coffin V; Cohen-Williams M; Barnett A
Eur J Pharmacol; 1994 Apr; 256(2):R9-10. PubMed ID: 8050461
[TBL] [Abstract][Full Text] [Related]
24. 3,5-Dihydro-4H-2,3-benzodiazepine-4-thiones: a new class of AMPA receptor antagonists.
Chimirri A; De Sarro G; De Sarro A; Gitto R; Quartarone S; Zappalà M; Constanti A; Libri V
J Med Chem; 1998 Aug; 41(18):3409-16. PubMed ID: 9719593
[TBL] [Abstract][Full Text] [Related]
25. Comparative effects of felbamate and other compounds on N-methyl-D-aspartic acid-induced convulsions and lethality in mice.
Sofia RD; Gordon R; Gels M; Diamantis W
Pharmacol Res; 1994; 29(2):139-44. PubMed ID: 8058587
[TBL] [Abstract][Full Text] [Related]
26. Felbamate block of the N-methyl-D-aspartate receptor.
Subramaniam S; Rho JM; Penix L; Donevan SD; Fielding RP; Rogawski MA
J Pharmacol Exp Ther; 1995 May; 273(2):878-86. PubMed ID: 7752093
[TBL] [Abstract][Full Text] [Related]
27. Felbamate selectively blocks in vitro hippocampal kainate-induced irreversible electrical changes.
Longo R; Domenici MR; Scotti de Carolis A; Sagratella S
Life Sci; 1995; 56(21):PL409-14. PubMed ID: 7537844
[TBL] [Abstract][Full Text] [Related]
28. Influence of a Ca2+ channel agonist, Bay k-8644, on the anticonvulsant activity of NMDA and non-NMDA receptor antagonists.
Czuczwar SJ; Gasior M; Turski WA; Kleinrok Z
Eur J Pharmacol; 1994 Oct; 264(1):103-6. PubMed ID: 7530200
[TBL] [Abstract][Full Text] [Related]
29. Interactions of MRZ 2/576 with felbamate, lamotrigine, oxcarbazepine and topiramate in the mouse maximal electroshock-induced seizure model.
Luszczki JJ; Danysz W; Czuczwar SJ
Pharmacology; 2008; 81(3):259-65. PubMed ID: 18253065
[TBL] [Abstract][Full Text] [Related]
30. Excitatory amino acid antagonists alleviate convulsive and toxic properties of lindane in mice.
Blaszczak P; Turski WA
Pharmacol Toxicol; 1998 Mar; 82(3):137-41. PubMed ID: 9553992
[TBL] [Abstract][Full Text] [Related]
31. Antagonism of various tonic convulsions in mice by dextrorphan and dizocilpine.
Akaike N; Himori N
Naunyn Schmiedebergs Arch Pharmacol; 1993 Jun; 347(6):652-7. PubMed ID: 7689706
[TBL] [Abstract][Full Text] [Related]
32. Effects of some excitatory amino acid antagonists and drugs enhancing gamma-aminobutyric acid neurotransmission on pefloxacin-induced seizures in DBA/2 mice.
De Sarro G; Nava F; Calapai G; De Sarro A
Antimicrob Agents Chemother; 1997 Feb; 41(2):427-34. PubMed ID: 9021202
[TBL] [Abstract][Full Text] [Related]
33. 5-(N-oxyaza)-7-substituted-1,4-dihydroquinoxaline-2,3-diones: novel, systemically active and broad spectrum antagonists for NMDA/glycine, AMPA, and kainate receptors.
Cai SX; Huang JC; Espitia SA; Tran M; Ilyin VI; Hawkinson JE; Woodward RM; Weber E; Keana JF
J Med Chem; 1997 Oct; 40(22):3679-86. PubMed ID: 9357535
[TBL] [Abstract][Full Text] [Related]
34. Effects of felbamate on veratridine- and K(+)-stimulated release of glutamate from mouse cortex.
Srinivasan J; Richens A; Davies JA
Eur J Pharmacol; 1996 Nov; 315(3):285-8. PubMed ID: 8982666
[TBL] [Abstract][Full Text] [Related]
35. Antagonism of convulsions but failure to enhance GABA(A) receptor function by felbamate in mice tolerant to diazepam.
Serra M; Cuccu R; Ghiani CA; Pisu MG; Murgia A; Biggio G
Neurochem Res; 1997 Jun; 22(6):693-7. PubMed ID: 9178952
[TBL] [Abstract][Full Text] [Related]
36. Anticonvulsant and behavioral profile of L-701,324, a potent, orally active antagonist at the glycine modulatory site on the N-methyl-D-aspartate receptor complex.
Bristow LJ; Hutson PH; Kulagowski JJ; Leeson PD; Matheson S; Murray F; Rathbone D; Saywell KL; Thorn L; Watt AP; Tricklebank MD
J Pharmacol Exp Ther; 1996 Nov; 279(2):492-501. PubMed ID: 8930150
[TBL] [Abstract][Full Text] [Related]
37. 1-Aryl-3,5-dihydro-4H-2,3-benzodiazepin-4-ones: novel AMPA receptor antagonists.
Chimirri A; De Sarro G; De Sarro A; Gitto R; Grasso S; Quartarone S; Zappalà M; Giusti P; Libri V; Constanti A; Chapman AG
J Med Chem; 1997 Apr; 40(8):1258-69. PubMed ID: 9111300
[TBL] [Abstract][Full Text] [Related]
38. AMPA/kainate-related mechanisms contribute to convulsant and proconvulsant effects of 3-nitropropionic acid.
Urbanska EM; Blaszczak P; Saran T; Kleinrok Z; Turski WA
Eur J Pharmacol; 1999 Apr; 370(3):251-6. PubMed ID: 10334499
[TBL] [Abstract][Full Text] [Related]
39. Influence of combined treatment with NMDA and non-NMDA receptor antagonists on electroconvulsions in mice.
Czuczwar SJ; Borowicz KK; Kleinrok Z; Tutka P; Zarnowski T; Turski WA
Eur J Pharmacol; 1995 Aug; 281(3):327-33. PubMed ID: 8521917
[TBL] [Abstract][Full Text] [Related]
40. Excitatory amino acid antagonists, lamotrigine and BW 1003C87 as anticonvulsants in the genetically epilepsy-prone rat.
Smith SE; al-Zubaidy ZA; Chapman AG; Meldrum BS
Epilepsy Res; 1993 Jun; 15(2):101-11. PubMed ID: 8103738
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
